Alembic Pharma Secures USFDA Approval for Generic Seizure Medication Lamotrigine ER
Alembic Pharmaceuticals has announced that it has received final approval from the US Food and Drug Administration (USFDA) to market […]
USD-163-MILLION-SEIZURE-DRUG-MARKET
